NCR3 and non-small cell lung carcinoma: Indeed, increase in NKp30-mediated IFNγ and TNFα production by circulating NK cells was observed upon four IFNγ DCexo vaccinations, although NK cells in these advanced NSCLC patients only exhibited low levels of NKp30.